Skip to main content
Caplight Logo









Toxometris

Toxometris

Private
United StatesHealthcare & Life Scienceshttps://toxometris.ai/

Last Round

Pre Seed

Nov 6, 2023

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Toxometris is a biotechnology company that provides AI-powered in silico toxicology screening services for drug discovery and chemical development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Compliance & Risk, Vertical SaaS

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

in-silico toxicologychemical safety assessmentADMET predictiondrug discoverycomputational toxicologyAI drug discoverySMILESpredictive toxicologyanimal testing alternativesNAMsnew approach methodologiesQMRFOECD-compliantchemical screeningtoxicology softwareAI safety platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Toxometris Comparables

Compare Toxometris with similar companies based on industry and business-model similarity.

Toxometris comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Axiom Bio
86%
MultiCASE Inc.
83%
Greenstone Biosciences
79%

Toxometris Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedNov 6, 2023
AcceleratorJan 25, 2022

Toxometris Investors

Notable investors and investment history

Toxometris investors
InvestorRounds
Armenia Startup AcademyAccelerator
SmartGateVCPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors grew 721% MoM, from 295 to 2.4K.

  • Oct 18, 2024

    Grew 100% QoQ from 3 to 6 employees.

Toxometris Filings

Explore SEC and related filing metadata, where available.

Toxometris filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Toxometris's valuation, stock price, and market status.

Is Toxometris a public or private company?

Toxometris is a private company.

What is the current stock price of Toxometris?

Toxometris is a private company with no public stock price. No recent secondary market data is available.

How much is Toxometris worth (valuation)?

Valuation information for Toxometris is not publicly available.

Can I buy Toxometris stock?

Toxometris shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Toxometris's last funding round?

Toxometris's most recent funding round was Pre Seed on November 6, 2023.

Who are the main investors in Toxometris?

Key investors in Toxometris include SmartGateVC.

Will Toxometris IPO soon?

No public IPO plans have been announced for Toxometris.

How can I track Toxometris secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Toxometris's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUnited States
Employee Range5
Year FoundedN/A
Last FundingNov 6, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?